Roche Holding Valuation
| RO Stock | CHF 267.80 2.20 0.81% |
At this time, the company appears to be overvalued. Roche Holding AG holds a recent Real Value of ₣235.66 per share. The prevailing price of the company is ₣267.8. Our model determines the value of Roche Holding AG from analyzing the company fundamentals such as Return On Equity of 0.45, operating margin of 0.32 %, and Shares Outstanding of 106.69 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Roche Holding's price fluctuation is very steady at this time. Calculation of the real value of Roche Holding AG is based on 3 months time horizon. Increasing Roche Holding's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Roche stock is determined by what a typical buyer is willing to pay for full or partial control of Roche Holding AG. Since Roche Holding is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Roche Stock. However, Roche Holding's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 267.8 | Real 235.66 | Hype 267.8 | Naive 271.91 |
The intrinsic value of Roche Holding's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Roche Holding's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Roche Holding AG helps investors to forecast how Roche stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Roche Holding more accurately as focusing exclusively on Roche Holding's fundamentals will not take into account other important factors: Roche Holding Total Value Analysis
Roche Holding AG is at this time projected to have takeover price of 274.42 B with market capitalization of 223.6 B, debt of 22.28 B, and cash on hands of 2.15 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Roche Holding fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
274.42 B | 223.6 B | 22.28 B | 2.15 B |
Roche Holding Investor Information
About 75.0% of the company outstanding shares are owned by corporate insiders. The company recorded earning per share (EPS) of 17.69. Roche Holding AG last dividend was issued on the 16th of March 2023. The entity had 100:1 split on the 4th of May 2011. Roche Holding AG is not in a good financial situation at the moment. It has a very high risk of going through financial straits in August.Roche Holding Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Roche Holding has an asset utilization ratio of 71.79 percent. This indicates that the Company is making ₣0.72 for each dollar of assets. An increasing asset utilization means that Roche Holding AG is more efficient with each dollar of assets it utilizes for everyday operations.Roche Holding Ownership Allocation
Roche Holding owns a total of 106.69 Million outstanding shares. Roche Holding holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 75.31 pct. of Roche Holding AG outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Roche Holding Profitability Analysis
The company reported the revenue of 63.28 B. Net Income was 13.53 B with profit before overhead, payroll, taxes, and interest of 47.83 B.About Roche Holding Valuation
Our relative valuation model uses a comparative analysis of Roche Holding. We calculate exposure to Roche Holding's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Roche Holding's related companies.Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company was founded in 1896 and is headquartered in Basel, Switzerland. ROCHE I operates under Drug ManufacturersGeneral classification in Switzerland and is traded on Switzerland Exchange. It employs 100920 people.
8 Steps to conduct Roche Holding's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Roche Holding's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Roche Holding's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Roche Holding's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Roche Holding's revenue streams: Identify Roche Holding's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Roche Holding's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Roche Holding's growth potential: Evaluate Roche Holding's management, business model, and growth potential.
- Determine Roche Holding's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Roche Holding's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Additional Tools for Roche Stock Analysis
When running Roche Holding's price analysis, check to measure Roche Holding's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roche Holding is operating at the current time. Most of Roche Holding's value examination focuses on studying past and present price action to predict the probability of Roche Holding's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roche Holding's price. Additionally, you may evaluate how the addition of Roche Holding to your portfolios can decrease your overall portfolio volatility.